ask="0.46"
ask_size="400"
average_daily_volume="1753250"
bid="0.25"
bid_size="400"
book_value="0.17"
change="+0.01"
change_from_200_day_moving_average="-0.04"
change_from_50_day_moving_average="0.00"
change_from_52_week_high="-0.81"
change_From_52_week_low="0.03"
change_in_percent="+3.44%"
close="0.31"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.20"
ebitda="-41.64M"
eps_estimate_current_year="-0.13"
eps_estimate_next_quarter="-0.03"
eps_estimate_next_year="-0.11"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.31"
high_52_weeks="1.12"
last_trade_date="2/1/2017"
last_trade_price="0.31"
last_trade_size="1481"
last_trade_time="4:00pm"
low="0.29"
low_52_weeks="0.28"
market_capitalization="79.71M"
moving_average_200_day="0.35"
moving_average_50_day="0.31"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.25"
open="0.30"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-10.71%"
percent_change_from_50_day_moving_average="+1.49%"
percent_change_from_52_week_high="-72.32%"
percent_change_from_52_week_low="+9.93%"
previous_close="0.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.78"
price_per_sales="1.41"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.33"
stock_exchange="NCM"
symbol="PPHM"
volume="1287118"
weeks_range_52="0.28 - 1.12"
